Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis
JOURNAL OF VIRAL HEPATITIS, cilt.8, sa.5, ss.372-376, 2001 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 8 Sayı: 5
- Basım Tarihi: 2001
- Doi Numarası: 10.1046/j.1365-2893.2001.00301.x
- Dergi Adı: JOURNAL OF VIRAL HEPATITIS
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.372-376
- Anahtar Kelimeler: alcoholic liver disease, chronic liver disease, hepatitis B virus, hepatitis C virus, immunization, vaccine, CHRONIC LIVER-DISEASE, ACTIVATION PATHWAYS, ANTIBODY-RESPONSE, SURFACE-ANTIGEN, INFECTION
- Ankara Üniversitesi Adresli: Evet
Özet
Hepatitis B virus (HBV) vaccination is recommended for individuals with chronic liver disease. However, the response to standard doses of hepatitis B vaccines in such individuals has been poor. The aim of the present study was to assess the response to high-dose short-interval HBV vaccination in individuals with chronic liver disease of different aetiologies. A total two hundred and 24 subjects with chronic liver disease (138 chronic active hepatitis and 86 cirrhosis) and 26 healthy controls were vaccinated using a high-dose (40 mug) short-interval (monthly for 3 consecutive months) HBV vaccination schedule.